Literature DB >> 10661409

Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.

T Ohtani1, K Ishihara, T Atsumi, K Nishida, Y Kaneko, T Miyata, S Itoh, M Narimatsu, H Maeda, T Fukada, M Itoh, H Okano, M Hibi, T Hirano.   

Abstract

We generated a series of knockin mouse lines, in which the cytokine receptor gp130-dependent STAT3 and/or SHP2 signals were disrupted, by replacing the mouse gp130 gene with human gp130 mutant cDNAs. The SHP2 signal-deficient mice (gp130F759/F759 were born normal but displayed splenomegaly and lymphadenopathy and an enhanced acute phase reaction. In contrast, the STAT3 signal-deficient mice (gp130FXQ/FXXQ) died perinatally, like the gp130-deficient mice (gp130D/D). The gp130F759/F759 mice showed prolonged gp130-induced STAT3 activation, indicating a negative regulatory role for SHP2. Th1-type cytokine production and IgG2a and IgG2b production were increased in the gp130F759/F759 mice, while they were decreased in the gp130FXXQ/FXXQ immune system. These results indicate that the balance of positive and negative signals generated through gp130 regulates the immune responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661409     DOI: 10.1016/s1074-7613(00)80162-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  77 in total

Review 1.  Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation".

Authors:  Jr-Gang Cheng; Clara I Rodriguez; Colin L Stewart
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Specific targeting of IL-6 signalling pathway: a new way to treat IBD?

Authors:  P Desreumaux
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells.

Authors:  Longbiao Yao; Takafumi Yokota; Lijun Xia; Paul W Kincade; Rodger P McEver
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 4.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

5.  Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.

Authors:  J G Cheng; J R Chen; L Hernandez; W G Alvord; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 6.  Interaction of Notch and gp130 signaling in the maintenance of neural stem and progenitor cells.

Authors:  Hana Kotasová; Jiřina Procházková; Jiří Pacherník
Journal:  Cell Mol Neurobiol       Date:  2013-10-17       Impact factor: 5.046

Review 7.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

8.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  Psoriatic inflammation facilitates the onset of arthritis in a mouse model.

Authors:  Mayuko Yamamoto; Kimiko Nakajima; Mikiro Takaishi; Shun Kitaba; Yasuhiro Magata; Sayo Kataoka; Shigetoshi Sano
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

10.  Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.

Authors:  In Ohk Lee; Jie Hyun Kim; Yeun Jung Choi; Michael H Pillinger; Seok-Yong Kim; Martin J Blaser; Yong Chan Lee
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.